20837948

Source:http://linkedlifedata.com/resource/pubmed/id/20837948

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0034656, umls-concept:C0045093, umls-concept:C0282460, umls-concept:C0346647, umls-concept:C0728940, umls-concept:C1522673, umls-concept:C1880198
pubmed:issue	29
pubmed:dateCreated	2010-10-8
pubmed:abstractText	The role of adjuvant chemoradiotherapy (CRT) in resectable pancreatic cancer is still debated. This randomized phase II intergroup study explores the feasibility and tolerability of a gemcitabine-based CRT regimen after R0 resection of pancreatic head cancer.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/5U10 CA11488-30, http://linkedlifedata.com/resource/pubmed/grant/5U10 CA11488-31, http://linkedlifedata.com/resource/pubmed/grant/5U10 CA11488-32, http://linkedlifedata.com/resource/pubmed/grant/5U10 CA11488-33, http://linkedlifedata.com/resource/pubmed/grant/5U10 CA11488-34, http://linkedlifedata.com/resource/pubmed/grant/5U10 CA11488-35, http://linkedlifedata.com/resource/pubmed/grant/5U10 CA11488-36, http://linkedlifedata.com/resource/pubmed/grant/5U10 CA11488-37, http://linkedlifedata.com/resource/pubmed/grant/5U10 CA11488-38, http://linkedlifedata.com/resource/pubmed/grant/5U10 CA11488-39, http://linkedlifedata.com/resource/pubmed/grant/5U10 CA11488-40
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites, Antineoplastic, http://linkedlifedata.com/resource/pubmed/chemical/Deoxycytidine, http://linkedlifedata.com/resource/pubmed/chemical/gemcitabine
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	1527-7755
pubmed:author	pubmed-author:BudachVolkerV, pubmed-author:CoatJ PJP, pubmed-author:ColletteLaurenceL, pubmed-author:HammelPascalP, pubmed-author:HaustermansKarinK, pubmed-author:LutzManfredM, pubmed-author:MauerMurielleM, pubmed-author:MornexFrançoiseF, pubmed-author:PeetersMarcM, pubmed-author:PolusMarcM, pubmed-author:PraetMichelM, pubmed-author:Van CutsemEricE, pubmed-author:Van LaethemJean-LucJL, pubmed-author:Van TienhovenGeertjanG, pubmed-author:VergauwePhilippeP
pubmed:issnType	Electronic
pubmed:day	10
pubmed:volume	28
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	4450-6
pubmed:dateRevised	2011-10-10
pubmed:meshHeading	pubmed-meshheading:20837948-Adult, pubmed-meshheading:20837948-Aged, pubmed-meshheading:20837948-Antimetabolites, Antineoplastic, pubmed-meshheading:20837948-Chemotherapy, Adjuvant, pubmed-meshheading:20837948-Combined Modality Therapy, pubmed-meshheading:20837948-Deoxycytidine, pubmed-meshheading:20837948-Diarrhea, pubmed-meshheading:20837948-Drug Administration Schedule, pubmed-meshheading:20837948-Fatigue, pubmed-meshheading:20837948-Feasibility Studies, pubmed-meshheading:20837948-Female, pubmed-meshheading:20837948-Humans, pubmed-meshheading:20837948-Kaplan-Meier Estimate, pubmed-meshheading:20837948-Male, pubmed-meshheading:20837948-Middle Aged, pubmed-meshheading:20837948-Nausea, pubmed-meshheading:20837948-Pancreatic Neoplasms, pubmed-meshheading:20837948-Radiotherapy, Adjuvant, pubmed-meshheading:20837948-Treatment Outcome
pubmed:year	2010
pubmed:articleTitle	Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study.
pubmed:affiliation	Department of Gastroenterology, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium. JL.Vanlaethem@erasme.ulb.ac.be
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase II, Research Support, N.I.H., Extramural